ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 225,64
0,16%
DAX
18 235,45
0,17%
Brent Oil
84,94
-0,56%
Bitcoin
60 923,67
-1,12%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PMV Pharmaceuticals Inc (PMVP)

  7. PMV Pharmaceuticals Inc (PMVP) Actualités

PMVP PMV Pharmaceuticals Inc

1,635
-0,025 (-1,51%)
Dernière mise à jour : 17:38:39
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PMV Pharmaceuticals Inc PMVP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,025 -1,51% 1,635 17:38:39
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,68 1,62 1,695 1,66
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202414:32EDGAR2Form 8-K - Current report
30/5/202413:00GLOBEPMV Pharmaceuticals to Participate at Upcoming Investor..
29/5/202413:00BWFoundation Medicine and PMV Pharma Announce Collaboration to..
09/5/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:00EDGAR2Form 8-K - Current report
09/5/202414:00GLOBEPMV Pharmaceuticals Reports First Quarter 2024 Financial..
27/3/202413:00GLOBEPMV Pharmaceuticals Announces First Patient Dosed in Global..
18/3/202421:01GLOBEPMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in..
29/2/202422:05EDGAR2Form 8-K - Current report
29/2/202422:01GLOBEPMV Pharmaceuticals Reports Full Year 2023 Financial Results..
26/2/202414:00GLOBEPMV Pharmaceuticals to Participate in the TD Cowen 44th..
24/1/202415:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:02EDGAR2Form 8-K - Current report
18/1/202422:01GLOBEPMV Pharmaceuticals Announces Prioritization of PC14586..
11/1/202422:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202422:01EDGAR2Form 8-K - Current report
05/1/202422:01GLOBEPMV Pharmaceuticals Strengthens Leadership with Key..
09/11/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202314:00EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEPMV Pharmaceuticals Reports Third Quarter 2023 Financial..
12/10/202323:02EDGAR2Form 8-K - Current report
12/10/202318:30GLOBEPMV Pharmaceuticals Updated PC14586 Phase 1 Data..
11/10/202322:02EDGAR2Form 8-K - Current report
11/10/202318:00GLOBEPMV Pharmaceuticals to Present Updated Phase 1 Data on..
20/9/202322:05GLOBEPMV Pharmaceuticals to Present Updated Phase 1 Data on..
18/9/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:00EDGAR2Form 8-K - Current report
09/8/202314:00GLOBEPMV Pharmaceuticals Reports Second Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
PMVP
PMV Pharmaceuticals
TSXV
SVX
LSE
AU85
Cov.bs.33
LSE
SEUR
Wt S Eur L Usd
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés